David Knechtel

Vice President And General Manager, UK & Ireland at argenx

David Knechtel is the Vice President and General Manager at argenx, leading the launch of efgartigimod in Europe. With extensive experience in pharmaceutical companies like Otsuka and Johnson & Johnson across Europe and the UK, David has a strong background in sales, marketing, and business development. David holds an MBA from Duke University, emphasizing in Health Sector Management.

Links

Previous companies

Johnson & Johnson logo

Timeline

  • Vice President And General Manager, UK & Ireland

    February 1, 2023 - present

  • Head Of EMA Sales & Marketing And General Manager, UK & Ireland

    February, 2022

  • Vice President, Head Of EMA Sales & Marketing

    October, 2021

View in org chart